Tumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesis

Jeremy Williams,Roman Camarda,Serghei Malkov,Lisa J Zimmerman,Suzanne Manning,Dvir Aran,Andrew Beardsley,Daniel Van de Mark,Yong Chen,Charles A Berdan,Sharon M Louie,Celine Mahieu,Daphne Superville,Juliane Winkler,Elizabeth Willey,John D Gagnon,Seda Kilinc Avsaroglu,Kosaku Shinoda,Matthew Gruner,Hiroshi Nishida,Karl Mark Ansel,Zena Werb,Daniel K Nomura,Shingo Kajimura,Atul J Butte,Melinda E Sanders,Daniel C Liebler,Hope Rugo,Gregor Krings,John A Shepherd,Andrei Goga

DOI: https://doi.org/10.1101/277939

2024-10-03

Abstract:A pro-tumorigenic role for adipocytes has been identified in breast cancer, and reliance on fatty acid catabolism found in aggressive tumors. The molecular mechanisms by which tumor cells coopt neighboring adipocytes, however, remain elusive. Here, we describe a direct interaction linking tumorigenesis to adjacent adipocytes. We examine breast tumors and their normal adjacent tissue from several patient cohorts, patient-derived xenografts and mouse models, and find that lipolysis and lipolytic signaling are activated in neighboring adipose tissue. We find that functional gap junctions form between breast cancer cells and adipocytes. As a result, cAMP is transferred from breast cancer cells to adipocytes and activates lipolysis in a gap junction-dependent manner. We identify connexin 31 (GJB3), which promotes receptor triple negative breast cancer growth and activation of lipolysis in vivo. Thus, direct tumor cell-adipocyte interaction contributes to tumorigenesis and may serve as a new therapeutic target in breast cancer.

Cancer Biology